Liver Research Matters - Read our blog to learn more!

The Value of Liver Research

October 14, 2022 | By | Liver Disease, Liver Health | Blog, Clinical research, Fatty Liver Disease, Liver research

  Worldwide, liver cancer is the second most common cause of cancer-related death. Yet, with such prevalence, it remains challenging to treat. As numbers continue to rise, the value of liver research is critical to public health. Learn more about …

Why Minority Participation in Liver Research Matters

Why Minority Participation in Liver Research Matters

April 7, 2022 | By | Clinical Trials, Liver Disease, Minority Participation in Liver Research | Blog, Diversity in research, Fatty Liver Disease, NAFLD, NASH, National Minority Health Month

April is National Minority Health Month (NMHM), a time to raise awareness about health disparities that affect people from racial and ethnic minority groups. Liver disease is growing in prevalence in the Hispanic population. It is also a leading cause …

Liver disease doesn't discriminate

Liver Disease in Women

March 7, 2022 | By | Fibroscan, Liver Disease | Blog, NAFLD, NASH, Women's History Month

March is Women’s History Month, and it commemorates women’s contributions to history, culture, and society. The 2022 theme is “Women Providing Healing, Promoting Hope.” It is a tribute to the countless ways women of all cultures provide healing and hope …

Know the stages of cirrhosis

From Liver Disease to Cirrhosis

August 26, 2021 | By | Cirrhosis, Clinical Trials, Liver Disease | Blog, NAFLD, NASH

Cirrhosis is when the permanent scarring of the liver has replaced the healthy tissue. While cirrhosis is most often associated with chronic alcohol consumption, it is brought about by many types of liver disease. Here’s how you get from liver disease …

Calling all caregivers! Read our latest blog on tips for being a caregiver of someone with liver disease

Tips for Caregivers

August 4, 2021 | By | Clinical Trials, Liver Disease | Blog, Caregiving, Clinical research, NAFLD, NASH

Having liver disease affects the person with it but also loved ones around them. Often a family member or friend fills the role of meeting a variety of physical and emotional needs. If you are a caregiver for someone with …

Hispanic adults may be at risk

Liver Disease and the Hispanic Population

July 13, 2021 | By | Clinical Trials, Liver Disease | Blog, Clinical trials, NAFLD, NASH

The number of U.S. adults with non-alcoholic fatty liver disease (NAFLD) currently sits around 25%. Approximately 2-3% of them will go on to develop non-alcoholic steatohepatitis (NASH). NASH is a more severe form of NAFLD and can lead to fibrosis, …